Yoshirai Arai & Steve Engen
Solasia Pharma is changing its management team and has promoted Yoshirai Arai (left) to position of President and Representative Director of the company.
Present CEO, Steve Engen (right), has also announced he is resigning in order to pursue a new career opportunity.
Arai spent 14 years at Amgen before arriving at Solasia in 2007.
Arai said: “I look forward to taking on this important role and responsibility in order to continue to build Solasia. We will accelerate our clinical programs in Asia, and will establish a new sales & marketing organization for commercialization of our 1st product in China. In addition, we will seek new compounds to strengthen our pipeline.”